Clinical Trials Browser

Phase 1/2 × Desmoplastic Small Round Cell Tumor × Ramucirumab × Clear all

NCT04145349 2026-05-11

CAMPFIRE: A Study of Ramucirumab (LY3009806) in Children and Young Adults With Desmoplastic Small Round Cell Tumor

Phase 1/2 Completed

30 enrolled 16 charts

Sarcoma, Desmoplastic Small Round Cell Tumor